These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1761417)

  • 1. An NMR study of eremomycin and its derivatives. Full 1H and 13C assignment, motional behavior, dimerization and complexation with Ac-D-Ala-D-Ala.
    Batta G; Sztaricskai F; Kövér KE; Rüdel C; Berdnikova TF
    J Antibiot (Tokyo); 1991 Nov; 44(11):1208-21. PubMed ID: 1761417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN
    J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
    Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
    Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance.
    Kim SJ; Cegelski L; Preobrazhenskaya M; Schaefer J
    Biochemistry; 2006 Apr; 45(16):5235-50. PubMed ID: 16618112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal.
    Pavlov AY; Berdnikova TF; Olsufyeva EN; Lazhko EI; Malkova IV; Preobrazhenskaya MN; Testa RT; Petersen PJ
    J Antibiot (Tokyo); 1993 Nov; 46(11):1731-9. PubMed ID: 8270496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies.
    Izsépi L; Erdei R; Tevyashova AN; Grammatikova NE; Shchekotikhin AE; Herczegh P; Batta G
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33499349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
    Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
    J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
    Xing B; Jiang T; Wu X; Liew R; Zhou J; Zhang D; Yeow EK
    Chemistry; 2011 Dec; 17(50):14170-7. PubMed ID: 22083883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
    Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
    Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of dimerization of polysynthetic derivatives of the antibiotic eremomycin by ESI MS and its role in elucidating antibacterial activity].
    Mirgorodskaia OA; Olsuf'eva EN; Kolume DE; Joergensen TJ; Roepstorff P; Pavlov AIu; Miroshnikova OV; Preobrazhenskaia MN
    Bioorg Khim; 2000 Aug; 26(8):631-40. PubMed ID: 11041003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies.
    Sztaricskai F; Batta G; Herczegh P; Balázs A; Jeko J; Roth E; Szabó PT; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2006 Sep; 59(9):564-82. PubMed ID: 17136889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of concentrations of equilibrium components in an in vitro activity test of vancomycin antibiotics and the possible mode of action.
    Yan H; Cheng X; He B
    Biophys Chem; 1998 Aug; 74(2):107-15. PubMed ID: 9760722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy.
    Clore GM; Bax A; Driscoll PC; Wingfield PT; Gronenborn AM
    Biochemistry; 1990 Sep; 29(35):8172-84. PubMed ID: 2261471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New chiral stationary phase with macrocyclic glycopeptide antibiotic eremomycin chemically bonded to silica.
    Staroverov SM; Kuznetsov MA; Nesterenko PN; Vasiarov GG; Katrukha GS; Fedorova GB
    J Chromatogr A; 2006 Mar; 1108(2):263-7. PubMed ID: 16464461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.
    Groves P; Searle MS; Mackay JP; Williams DH
    Structure; 1994 Aug; 2(8):747-54. PubMed ID: 7994574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eremomycin--new glycopeptide antibiotic: chemical properties and structure.
    Gause GF; Brazhnikova MG; Lomakina NN; Berdnikova TF; Fedorova GB; Tokareva NL; Borisova VN; Batta GY
    J Antibiot (Tokyo); 1989 Dec; 42(12):1790-7. PubMed ID: 2621162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained.
    Pavlov AY; Olsufyeva EN; Berdnikova TF; Malkova IV; Preobrazhenskaya MN; Risbridger GD
    J Antibiot (Tokyo); 1994 Feb; 47(2):225-32. PubMed ID: 8150719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of vancomycin and a vancomycin/D-Ala-D-Ala complex in solution.
    Molinari H; Pastore A; Lian LY; Hawkes GE; Sales K
    Biochemistry; 1990 Mar; 29(9):2271-7. PubMed ID: 2337603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu; Preobrazhenskaia MN
    Bioorg Khim; 1998 Sep; 24(9):644-62. PubMed ID: 9813730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.